About Inhibitex (NASDAQ:INHX)
Inhibitex, Inc. develops antibody-based products for the treatment and prevention of bacterial and fungal infections. The Company produces products that can be used as vaccines, binding inhibitors or separation supports for affinity purifications. The Company's lead product candidate, Veronate, which entered into Phase III clinical trial in the second half of 2004, is being developed for the prevention of hospital-associated infections in premature, very low birth weight, (VLBW) infants.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Inhibitex (NASDAQ:INHX) Frequently Asked Questions
What is Inhibitex's stock symbol?
Inhibitex trades on the NASDAQ under the ticker symbol "INHX."
Who are some of Inhibitex's key competitors?
Some companies that are related to Inhibitex include Johnson & Johnson (JNJ), Novartis (NVS), UnitedHealth Group (UNH), Pfizer (PFE), Roche (ROG), Merck & Co., Inc. (MRK), AbbVie (ABBV), Amgen (AMGN), Sanofi (SNY), Novo Nordisk A/S (NVO), Gilead Sciences (GILD), Abbott Laboratories (ABT), Bristol-Myers Squibb (BMY), Eli Lilly and (LLY), GlaxoSmithKline (GSK), Sanofi (SAN), AstraZeneca (AZN) and Bayer (BAYN).
How do I buy Inhibitex stock?
Shares of Inhibitex can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Inhibitex?
Inhibitex's mailing address is 9005 Westside Pkwy, ALPHARETTA, GA 30009-4783, United States. The healthcare company can be reached via phone at +1-678-7461100.
MarketBeat Community Rating for Inhibitex (INHX)MarketBeat's community ratings are surveys of what our community members think about Inhibitex and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Inhibitex (NASDAQ:INHX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Inhibitex (NASDAQ:INHX) Earnings History and Estimates Chart
Inhibitex (NASDAQ INHX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Inhibitex (NASDAQ:INHX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Inhibitex (NASDAQ:INHX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Inhibitex (NASDAQ INHX)
No insider trades for this company have been tracked by MarketBeat.com
Inhibitex (NASDAQ INHX) News Headlines
No headlines for this company have been tracked by MarketBeat.com
Inhibitex (NASDAQ:INHX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Inhibitex (NASDAQ:INHX) Income Statement, Balance Sheet and Cash Flow Statement
Inhibitex (NASDAQ INHX) Stock Chart for Tuesday, January, 16, 2018